Maternal diabetes is associated with an increased risk of several complications in the offspring, such as growth disturbances and congenital malformations (1) (2) (3) (4) . The malformation rate in the infants of diabetic mothers is 6 -9% (5-7) compared with 2-3% (2) in infants of nondiabetic mothers. Development of the heart, kidney, and CNS is often affected (1,8 -11) . The mechanism behind diabetic embryopathy and other diabetic complications, such as retinopathy, nephropathy, and neuropathy, is not known. However, analogous etiological mechanisms have been suggested for the three latter diabetic complications (12, 13) , mechanisms that may also play a role in diabetic embryopathy. Factors and processes that have been suggested to cause diabetic complications may therefore be investigated for their putative capacity to induce embryonic malformations. In addition, identifying the teratological factors in diabetic pregnancy may advance the understanding of all diabetic complications.
Several proposals have emerged to explain the origin of the diabetic embryopathy. Previous studies have suggested that increased glucose levels lead to malformations (14 -17) . In addition, oxidative stress (18, 19) , disturbances in the polyol pathway (20 -22) , and prostaglandin metabolism (23) (24) (25) (26) have been proposed to induce diabetic embryopathy.
It has been suggested that enhanced activity of PKC may be a common feature of all diabetic complications (12, 13) . In support of this notion, culture of bovine endothelial cells in high glucose concentration induces increased PKC activity (27) . However, a recent study has reported decreased PKC activity in Schwannoma cells cultured in high glucose concentration (28) , suggesting decreased activity of PKC as a factor in developing neuropathy, at least in some cell types.
Embryonic development and maldevelopment with respect to PKC activity have also been investigated. In a study of diabetic embryopathy in a mouse model it was reported that increased activity of PKC was correlated with congenital malformations (29) . Other studies have shown, however, that inhibition of PKC activity in rodent embryos may cause malformations (30, 31) , indicating that basal PKC activity is necessary for normal embryonic development. Evidently, clarifying the role of PKC in the etiology of diabetic embryopathy necessitates further investigation.
PKC belongs to serine/threonine kinases and participates in a variety of signal transduction pathways that affect many cellular processes such as proliferation, differentiation, and programmed cell death (32) . These pathways are important for the development of the embryo and several isoforms have been identified in embryonic tissues (␣, ␤, ␥, ␦, ⑀, , , , , ) (33, 34) . Altered PKC activity may therefore perturb embryonic development (30) . The activation of PKC entails a translocation of the enzymatic protein from the cytosol (inactive form) to the membrane (active form) (35) , a process reported for several PKC isoforms, e.g. PKC-␣ (36 -38), PKC-␤ (36 -38), PKC-␥ (37), PKC-␦ (37-39), PKC-⑀ (40), PKC-(41), and PKC- (38) . In this work, we used the Western blot-estimated amount of membrane-bound PKC protein normalized to total protein content as a marker for enzyme activity of each PKC isoform (42) (43) (44) . In addition, we used the ratio of immunoreactive membrane-bound PKC protein to immunoreactive cytosolic PKC protein as a measure of the extent of membrane translocation of PKC isoenzyme within each experimental group. Furthermore, we examined the mRNA levels and protein distribution of the PKC isoforms in embryos of normal and diabetic rats on gestational d 10 and 11. In particular, we compared markers of enzyme activity and protein distribution between malformed and nonmalformed embryos of diabetic rats and found differences for some isoenzymes, which are displayed below.
The aim was to characterize a possible association between altered PKC activity and disturbed embryonic development in a diabetic environment. We therefore chose to study the time interval of neural tube closure and heart formation (roughly corresponding to gestational d 9 -11 in the rat) inasmuch as the embryonic development of the nervous and cardiovascular systems is often severely affected by a diabetic milieu (10) .
MATERIALS AND METHODS

Animals
Embryos were obtained from normal and diabetic females of a local outbred Sprague-Dawley strain (about 10 pregnancies of each type) with an increased incidence of congenital malformations in diabetic pregnancy (45, 46) . All rats were fed a commercial pellet diet (AB Analycen, Lidköping, Sweden). The rats had free access to food and tap water and were maintained at an ambient temperature of 22°C with a 12-h light/dark cycle. Female and male rats were caged overnight and a positive vaginal smear the following morning designated gestational d 0.
Diabetes was induced with a single injection of 40 mg/kg streptozotocin (Sigma Chemical Co.-Aldrich Chemie, Stenheim, Germany) into a tail vein. Blood glucose was measured after 1 wk with a Glucose Analyzer 2 (Beckman Coulter, Inc., Fullerton, CA). Rats with a glucose concentration exceeding 20 mM were considered to be diabetic (D). After establishing the diabetic status, mating of the D females commenced.
On gestational d 10 and 11, the normal and diabetic rats were killed by cervical dislocation. Days 10 and 11 were chosen because these days allowed study of embryogenesis both in vitro and in vivo. The uterus was dissected out. Each embryo was carefully freed of their deciduas and membranes and transferred to a new Petri dish containing PBS.
The Animal Ethical Committee of the Medical Faculty of Uppsala University approved the research protocol including all experimental procedures involving animals.
Estimation of PKC Activity Markers (Western Blot)
Fractionation of embryonic cells. The embryos were washed in PBS before they were lysed with a Kontes Pellet Pestle motor hand homogenizer in buffer (20 mM Tris-Hcl, pH 7.5, 0.25 M sucrose, 5 mM EDTA, 0.2% Triton, 10 mM Benzamidine, 50 mM ␤-mercaptoethanol, 1 mM phenyl methyl sulfonyl fluoride). The homogenized sample was allowed to lysate for 5-10 min. Then 20 L of the lysed sample was drawn and stored for protein determination before spinning down cell debris and nuclei. A cold Beckman rotor was loaded with the supernatant transferred to centrifuge tubes. The samples were spun at 160,000 g for 20 min in a Beckman Airfuge (Beckman Coulter, Inc.). The supernatant (cytosolic fraction) was transferred to clean tubes and stored on ice. The pellet (membrane fraction) was resuspended in 30 L loading buffer. The cytosolic fraction was precipitated with 3 volumes of acetone. The precipitated proteins were centrifuged for 10 min in the cold environment. The acetone was poured out and the pellet was suspended in 30 L loading buffer. The samples were heated to 100°C for 2-3 min before they were applied at a 5% stacking gel with a 7% running gel. Next, 25 L of each sample was added to the wells and Full Range Rainbow (Amersham Pharmacia Biotech UK, Ltd., Little Chalfont, Buckinghamshire, UK) was used as a marker. The gel was run with 14 mA for 1 h. After electrophoresis the gel was put in Western blot buffer for 10 -15 min. Protran nitrocellulosemembrane (Schleicher & Shuell, Dassel, Germany) was used for the transfer that proceeded overnight at 30 V.
Immunoblot analysis. The membranes were pretreated with nonfat dry milk to block nonspecific binding (50 mL 1ϫ PBS, 2.5 g milk powder, 100 L 10% NaN 3 , 100 L Tween) for 1 h. Primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was diluted in block buffer, 25 L to 25 mL. Membranes were rinsed for 1.5 h on a shake board and washed with PBS-Tween 2 ϫ 10 min. They were then incubated with the secondary antibody (anti-rabbit Ig, Amersham Pharmacia Biotech UK, Ltd.) diluted 1:1000 in 25 mL of PBS-Tween ϩ 2.5% BSA (Bayer Corporation, Elkhart, IN).
Two milliliters of solution A and 50 L of solution B (ECL ϩ Western blotting detection system, RPN 2132, Amersham Pharmacia Biotech UK, Ltd.) were mixed in a centrifuge tube and were applied drop-wise on the membrane. After 5 min, the fluid was removed with a Whatman paper. The membranes were confined in plastic film, with the proteins upward, and placed in an exposure box. Film (Hyperfilm MP, 18 ϫ 24 cm, Amersham Pharmacia Biotech UK, Ltd.) was applied in a darkroom and was exposed for 1 min. Another film was applied, but this time exposed for 4 min. The film was developed with Agfa Curix 60.
The developed film was scanned to a computer and evaluated densitometrically with Kodak Digital Science 1D, ex-850 pressed in arbitrary units (AU). The densitometric measurement of the membrane and cytosolic fractions of each sample was normalized by division of the protein content of the whole sample and the resulting ratio, expressed as AU per microgram, was used as a measure of total PKC isoenzyme content. The membrane-bound fraction (divided with protein content) was subsequently used as a marker of isoenzyme activity (42) (43) (44) . When the isoenzyme activity differed between malformed and nonmalformed D embryos (no malformed N embryos were found), these activities were separately displayed (Fig. 1, d and e). The ratio between membrane-bound and cytosolic PKC protein was calculated as a measure of the extent of membrane translocation of PKC isoenzyme within each experimental group.
Measurement of protein.
Total protein content was estimated in each sample from an aliquot of 20 L lysate by the method of Lowry et al. (47) using BSA as standard.
Real-Time PCR Measurement of PKC Expression
Preparation of total RNA. Total RNA from embryos was isolated with RNeasy mini kit (QIAGEN AG, Basel, Switzerland) according to the manufacturer's description. Briefly, embryos from normal and diabetic rats were lysed in 350 L buffer. We did not distinguish between embryos with normal and abnormal morphology. Next, 350 L of 70% ethanol was added to the homogenates and the samples were mixed and applied to RNeasy mini spin columns, which were located in 2-mL collection tubes. The columns and tubes were centrifuged for 1 min at 13,000 rpm, the flow-through was discarded, and the columns were washed with 350 L wash buffer (RW1) and spun at 13,000 rpm for 1 min. The samples were DNase treated with 10 L DNase I and 70 L buffer (RDD) and incubated at room temperature for 25 min. Thereafter the columns were washed with 350 L wash buffer (RWI) and spun at 13,000 rpm for 1 min. The columns were subsequently washed with 500 L buffer (RPE) twice, the flow-through discarded after each centrifugation. The columns were transferred to new collection tubes and 50 L RNase-free water was applied to each column twice, and the accumulated flowthrough was collected after the centrifugation (total RNA sample). Then, 1 L of RNase inhibitor was added to each sample (RNA guard, Amersham Pharmacia Biotech UK, Ltd.). 
PKC IN RAT DIABETIC EMBRYOPATHY
Preparation of cDNA. One microgram of total RNA was used for reverse transcription. First-strand cDNA synthesis used first-strand beads (Ready To Go, Amersham Pharmacia Biotech AB, Uppsala, Sweden), according to the manufacturer's description. Then 30 L RNase-free water containing 1 L RNA was heated at 65°C for 10 min, then chilled on ice for 2 min. RNA solution was transferred to the First-Strand Reaction Mix Beads and the chosen primer was Oligo (dT). After incubation at 37°C for 60 min, the samples were heated to 95°C for 5 min. The resulting cDNA was diluted 3-fold with diethylpyrocarbonate-treated water.
Analysis of PKC mRNA levels. One microliter of the cDNA purified from embryos containing 10 ng of converted total RNA was amplified and measured with real-time PCR using the LightCycler (Roche Diagnostics GmbH, Mannheim, Germany). Specific primers were made by CyberGene AB (Huddinge, Sweden) ( Table 1) for PKC. According to the Light Cycler protocol, 1 L of the cDNA was amplified in a final volume of 10 L containing 6.2 L RNase-free water, 1 L FastStart DNA Master SYBR Green I (Roche Molecular Biochemicals, Mannheim, Germany), 2 mM MgCl 2 , and 0.5 M of the sense and antisense primers. For relative quantification, G6PDH was used as control (TIB Molbiol, Berlin, Germany) ( Table 1 ). The Light Cycler Run version 5.32 program was used with following parameters: 1) denaturation at 95°C for 10 min, and 2) amplification with a total of 45 cycles with each cycle with denaturation temperature at 95°C for 15 s, annealing temperature at 60°C for 10 s, and elongation temperature at 72°C for 15 s.
Controls were included in each run of the real-time PCR assay. For each primer pair one sample with no cDNA (containing only RNAse-free water) was included. Furthermore, to exclude the possibility of remaining DNA fragments in the samples, 10 ng of the total RNA of each sample was amplified in the Light Cycler. We found no PCR product in the water or in the total RNA samples. We excluded the essential AMV-RT enzyme in the cDNA preparation and found that no PCR product could be amplified.
In a separate pilot study, we compared the expression of G6PDH, actin, and ribosomal protein S-28 in embryos of normal and diabetic rats, and found G6PDH to yield the most stable expression (data not shown).
Results were analyzed for each sample with relative quantification comparing the difference between sample and control crossing point (Cp) values. To render a true value for mRNA levels the calculated difference were transformed according to the formula 2 Ϫ ͑Cpsample Ϫ CpG6 PDH͒ to yield the ratio PKC isoform/G6PDH.
Immunostaining of embryos
Embryos were fixed in 4% paraformaldehyde for 24 h and stored in 70% ethanol before they were embedded in paraffin. The embedded embryos were sliced in 5-M-thick sections and put on glass slides overnight.
The slides were deparaffinized, rehydrated, and rinsed in PBS. The sections were covered with 100 L trypsin diluted in 0.1% CaCl 2 for 10 min. Thereafter, the sections were washed with PBS for 10 min and subjected to 100 L 1% H 2 O 2 for 10 min. The slides were rinsed with PBS for 10 min and subjected to 100 L normal goat serum (Vector Laboratories, Burlingame, CA) for 30 min. We removed the goat serum and added either 100 L primary antibody PKC-␤1/␤2 (Santa Cruz Biotechnology) or 100 L blocking peptide (Santa Cruz Biotechnology) plus antibody PKC-␤1/␤2 before incubation overnight (Fig. 4, f-j; Fig. 5, f-j) .
Slides were washed in PBS for 10 min and incubated with secondary antibody (Dako EnVisionϩ Peroxidase, rabbit, ready to use) for 30 min. The slides were washed for 10 min and then developed with Fast 3,3'-diaminobenzidine tablet sets (Sigma Chemical Co.-Aldrich Chemie, Stenheim, Germany) for 5 min. Finally, the slides were mounted with coverslips. 
Statistical Considerations
Statistical significance was determined by ANOVA. In the case of significance (p Ͻ 0.05), individual groups were compared according to Fisher's protected least significant difference posthoc test. Analyses were performed using the program StatView for Macintosh (SAS Institute, Cary, NC).
RESULTS
Altered markers of PKC activity.
The activity of each PKC isoform was analyzed by Western blot for membrane (m) and cytosolic (c) associated fractions, normalized with protein content. The membrane-bound fraction (divided with protein content) was then used as a marker of isoenzyme activity (42) (43) (44) . When the isoenzyme activity differed between malformed and nonmalformed D embryos (no malformed N embryos were found), these activities were separately displayed (e.g. Fig. 1, d and e) . The m/c ratio was calculated as a measure of the extent of membrane translocation of PKC isoenzyme within each experimental group (Fig. 2) .
PKC-␣ showed increased activity in d-10 embryos from diabetic rats (D10) compared with embryos of control rats (N10). We found the opposite on gestational d 11, where D11 embryos had lower PKC-␣ activity than N11 embryos (Fig. 1a) .
PKC-␤1 showed increased activity on gestational d 10 in D10 embryos compared with N10 embryos, whereas PKC-␤1 activity did not differ between N11 and D11 embryos (Fig. 1b) .
PKC-␤2 showed no differences between N and D embryos, neither on d 10 nor on d 11 (Fig. 1c) .
The malformed D10 embryos (D10 malf) had higher PKC-␥ activity than the nonmalformed D10 embryos (D10 norm) and both had higher PKC-␥ activity than the N10 embryos. No such changes were found on gestational d 11 (Fig. 1d) . The intensity of the staining of the PKC-␥ bands was weaker and the bands were more difficult to detect than the stained bands of the other PKC isoforms.
The malformed D10 embryos (D10 malf) had higher PKC-␦ activity than the nonmalformed D10 embryos (D10 norm), which, in turn, was higher than the PKC-␦ activity in the N10 embryos (Fig. 1e) . On d 11, PKC-␦ activity did not differ between the different groups of embryos. The intensity of the PKC-␦ band was strong in all groups (Fig. 2e ).
There were no differences in PKC-⑀ activity between the groups, either on d 10 or d 11 (Fig. 1f) . 
PKC IN RAT DIABETIC EMBRYOPATHY
The D10 embryos showed increased PKC-activity compared with N10 embryos, whereas the D11 embryos had decreased PKC-activity compared with N11 embryo (Fig.  1g) . The intensity of the PKC-band was markedly strong in embryos on both d 10 and d 11.
Estimation of PKC isoenzyme translocation. The m/c ratio of PKC-␣ in the D10 embryos was markedly decreased compared with the m/c ratio of the N10 embryos, whereas the levels in the N11 and D11 embryos showed the same trend, but were more comparable (Fig. 2a) . The m/c ratios of PKC-␤1 did not differ between N and D embryos in the two age groups (Fig. 2b) . In contrast, the m/c ratio of PKC-␤2 was markedly higher in D embryos compared with N embryos both on d 10 and d 11. The m/c ratios of PKC-␥ did not differ between the d 10 and d 11. The m/c ratio of PKC-␦ in the malformed D10 embryos was increased compared with both N10 and D10 normal embryos. In addition, the m/c ratio of PKC-␦ in D11 malformed embryos was increased compared with N11 embryos (Fig. 2e ). There were no differences in PKC-⑀ m/c ratio between the groups, either on d 10 or d 11 (Fig. 2f) . With regard to PKC-, the D10 embryos showed a decreased m/c ratio compared with the m/c ratio of the N10 embryos, and the N and D embryos on d 11 showed the same trend (Fig. 2g) .
Measurement of PKC mRNA levels. The mRNA levels of PKC isoforms were investigated by real-time PCR.
The mRNA levels of PKC-␣ did not differ between N10 and D10 nor between N11 and D11 embryos (Fig. 3a) . We found higher mRNA levels of PKC-␤1 in D10 compared with N10 embryos. The mRNA levels of PKC-␤1 did not differ between N11 and D11 embryos (Fig. 3b) . PKC-␤2 mRNA levels did not differ between N10 and D10 nor between N11 and D11 embryos (Fig. 3c) . PKC-␥ mRNA levels did not differ between N10 and D10 embryos. The mRNA level of PKC-␥ in D11 embryos was lower than in N11 embryos (Fig. 3d) . PKC-␦ mRNA levels did not differ between the groups on gestational d 10 and 11 (Fig. 3e) . PKC-⑀ mRNA levels did not differ between the groups on gestational d 10 and 11 (Fig. 3f) . We found a higher mRNA level of PKC-in D10 than in N10 embryos but no differences in mRNA levels on gestational d 11 (Fig. 3g) .
PKC protein distribution in embryonic tissues. We investigated distribution and abundance of the PKC isoforms in embryos from N and D rats on gestational d 10 and 11 and found no differences between the groups with regard to PKC-␣, PKC-␥, PKC-␦, PKC-⑀, and PKC-(data not shown). In contrast, we found enhanced accumulation of PKC-␤1 and -␤2 proteins in the neural tube, heart, and facial tissues. We found no differences between N and D normal embryos; however, in D malformed embryos we found intensified staining for both PKC-␤1 and -␤2 compared with the N and D normal embryos 
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( Fig. 4, a-e, and Fig. 5, a-e) . As negative control we used the same staining procedure with a blocking peptide included, which effectively inhibited all specific staining (Fig. 4, f-j, and  Fig. 5, f-j) .
DISCUSSION
The major findings in the present study were the markers of increased activity of PKC-␣, PKC-␤1, PKC-␥, PKC-␦, and PKC-in embryos of diabetic rats and the specific and superimposed increase in markers of PKC-␥ and PKC-␦ activity in malformed embryos of diabetic rats. All of these changes were found on gestational d 10. In addition, we report increased immunohistochemical localization of PKC-␤1 and PKC-␤2 in malformed embryos of diabetic rats.
Our findings both resemble and differ with previous results. They support the view of an increased PKC activity in diabetes-exposed tissues but differ with earlier findings, inasmuch as the PKC activation in our hands was not constant but rather confined to a limited period of embryogenesis, mainly gestational d 10.
Disturbed embryonic development in a diabetic environment has been investigated in relation to changes in PKC activity (29, 31) . In a mouse model of diabetic embryopathy an association between exposure to a diabetic environment and enhanced embryonic PKC activity was recently reported (29) . On the other hand, inhibition of PKC has been shown to cause malformations in rodent embryos (30, 31) and, furthermore, administration of a PKC inhibitor to embryos subjected to teratogenic glucose concentrations in vitro failed to diminish the disturbed embryonic development (31) , thereby indicating the absolute requirement of a basal PKC activity for normal embryogenesis. Both high and low PKC activities have, therefore, been associated with disturbed embryogenesis in models of diabetic embryopathy. The stimulation of several PKC isoenzymes on gestational d 10 in the present study would support the notion of PKC activation as a component in the teratogenic process, or, alternatively, as an indicator of disturbed development in a diabetic environment.
The relation between a diabetic milieu and alterations in PKC activity is somewhat complex. Previous studies have identified one effect of increased ambient levels of glucose, a decreased uptake of inositol by the shared transport system (48) . A decreased intracellular level of inositol would yield decreased amounts of the phosphoinositides PI, PIP, PIP 2 , and DAG (49) , and a decreased activation of DAG-dependent isoforms of PKC (␣, ␤1, ␤2, ␥, ␦, ⑀, , ). This inhibiting effect of a diabetic environment on PKC activity may, on the other hand, be counterbalanced by an increased availability of DAG resulting from another set of consequences of the diabetic state, namely an enhanced flux and accumulation of metabolites in the glycolytic pathway. This enhanced glycolytic flux may inhibit the activity of the glycolytic enzyme GAPDH via overproduction of reactive oxygen species in the mitochondria (50) . The resulting inhibition of the glycolysis at the level of GAPDH would lead to accumulation of glycolytic metabolites upstream of this enzyme (51) . The increased availability of glyceraldehyde would provide increased amount of the backbone of DAG and, hence, stimulate PKC activity. Which one of these opposite influences that is predominant may vary between different tissues and developmental times, indeed also between embryonic and adult tissues. In the present study, we found evidence of enhanced PKC activity on gestational d 10 but not on gestational d 11 in rat embryonic tissues exposed to a diabetic environment.
In the present study, we used the normalized densitometrically determined membrane-bound fraction of each PKC isoenzyme as a measure of the enzymatic activity of this enzyme. We used the ratio of immunoreactive membrane-bound PKC protein to immunoreactive cytosolic PKC protein (m/c ratio) as a measure of the extent of membrane translocation of PKC isoenzyme within each experimental group
The association between structural defects in the embryo and enhanced activity of several PKC isoenzymes, found in the present study, is more enigmatic. If there is a causal relationship between these events, it may be inquired whether embryos that are damaged also develop a set of active PKC isoenzymes or whether PKC activation actually precedes and contributes to the embryonic dysmorphogenesis. Activation of PKC may 855 therefore either be a consequence of embryonic maldevelopment or may be involved in the induction of the developmental disturbance. This issue has to be addressed in future studies; however, inasmuch as inhibition of PKC activity does not protect rat embryos from glucose-induced dysmorphogenesis in vitro (31) , the notion of PKC activation as an indicator rather than a cause of embryonic maldevelopment has, at least so far, gained more support.
The mRNA levels of the seven isoforms of PKC were relatively constant regardless of gestational age or maternal metabolic condition. The developmental and physiologic consequences of the three changes recorded-i.e. increased mRNA levels of PKC-␤1 and PKC-on gestational d 10 in embryos of diabetic rats and decreased mRNA levels of PKC-␥ on d 11 in these embryos-are not evident. The changes in mRNA levels are roughly parallel to the changes in activity recorded for these three PKC isoenzymes; however, the majority of alterations in isoenzyme activity were not reflected in changes in gene expression. Therefore, it seems that the regulation of gene expression and the activity of the different PKC proteins are not identical.
With regard to the immunohistochemical demonstration of the PKC-␤1 and ␤2 isoforms there were no clear differences in staining between the embryos from normal rats and the nonmalformed embryos of diabetic rats. However, the malformed embryos from diabetic rats showed a stronger immunostaining compared with the embryos of the other groups. This suggests an association between embryonic maldevelopment on one hand and enhanced tissue distribution/activity of these two PKC isoenzymes on the other.
In malformed d-10 embryos from diabetic rats, we found a pronounced increase in activity markers of two PKC isoforms, PKC-␥ and PKC-␦. Whether this process is regulated at gene level is not apparent, the mRNA levels and the protein distribution of these two isoforms were not affected. This finding shows an association between embryonic maldevelopment and enhanced PKC-␥ and PKC-␦ activity; however, the possibility of a causal relationship between these events requires further studies.
In the present study, we investigated the activity of seven isoforms of PKC in embryos on gestational d 10 and 11. We found a general activation of five PKC isoenzymes (PKC-␣, PKC-␤1, PKC-␥, PKC-␦, and PKC-) in embryos of diabetic rats on gestational d 10. In addition, we found a superimposed activation of PKC-␥ and PKC-␦ in malformed embryos of diabetic rats on gestational d 10. This finding may suggest that diabetes provokes a general PKC activation in rodent embryos, as reported earlier (29) , resembling the activation found in adult endothelial (52) (53) (54) and retinal cells (55, 56) . However, this general PKC activation appears to be transient; we found unchanged or decreased PKC activities on gestational d 11 in embryos of diabetic rats compared with embryos of control rats. Taken together, the data of our study and other studies suggest an association between diabetic embryopathy and disturbed PKC activity. To determine whether and how these events are causally related will require further studies.
